Hormone Replacement Therapy Market Size, Share & Trend Report

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030

Report ID: 978-1-68038-784-1
Number of Pages: 123
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Hormone Replacement Therapy Market Product Outlook (Revenue, USD Million, 2018 - 2030)
- Estrogen and Progesterone Replacement Therapy
- HGH replacement therapy
- Thyroid hormone replacement therapy
- Testosterone Replacement Therapy
- Parathyroid Hormone replacement
Hormone Replacement Therapy Market Route of Administration Type Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Parenteral
- Transdermal
- Others
Hormone Replacement Therapy Market Disease type Outlook (Revenue, USD Million, 2018 - 2030)
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Hypoparathyroidism
Hormone Replacement Therapy Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
    - Estrogen and Progesterone Replacement Therapy
    - HGH replacement therapy
    - Thyroid hormone replacement therapy
    - Testosterone Replacement Therapy
    - Parathyroid Hormone replacement
  - North America Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
    - Oral
    - Parenteral
    - Transdermal
    - Others
  - North America Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
    - Menopause
    - Hypothyroidism
    - Male hypogonadism
    - Growth hormone deficiency
    - Hypoparathyroidism
  - U.S.
    - U.S. Hormone replacement therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - U.S. Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - U.S. Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth hormone deficiency
      - Hypoparathyroidism
  - Canada
    - Canada Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Canada Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Canada Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth hormone deficiency
      - Hypoparathyroidism
- Europe
  - Europe Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
    - Estrogen and Progesterone Replacement Therapy
    - HGH replacement therapy
    - Thyroid hormone replacement therapy
    - Testosterone Replacement Therapy
    - Parathyroid Hormone replacement
  - Europe Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
    - Oral
    - Parenteral
    - Transdermal
    - Others
  - Europe Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - UK
    - UK Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - UK Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - UK Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth hormone deficiency
      - Hypoparathyroidism
  - Germany
    - Germany Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Germany Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Germany Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - France
    - France Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - France Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - France Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - Italy
    - Italy Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Italy Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Italy Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - Spain
    - Spain Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Spain Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Spain Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - Denmark
  - Sweden
    - Sweden Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Sweden Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Sweden Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth hormone deficiency
      - Hypoparathyroidism
  - Norway
    - Norway hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Norway Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Norway Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
- Asia Pacific
- Latin America
- MEA
  - MEA Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
    - Estrogen and Progesterone Replacement Therapy
    - HGH replacement therapy
    - Thyroid hormone replacement therapy
    - Testosterone Replacement Therapy
    - Parathyroid Hormone replacement
  - MEA Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
    - Oral
    - Parenteral
    - Transdermal
    - Others
  - MEA Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - South Africa
    - South Africa Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - South Africa Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - South Africa Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
  - Saudi Arabia
    - Saudi Arabia hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Saudi Arabia Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Saudi Arabia Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth Hormone deficiency
      - Hypoparathyroidism
  - UAE
    - UAE Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - UAE Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - UAE Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth hormone deficiency
      - Hypoparathyroidism
  - Kuwait
    - Kuwait hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
      - Estrogen and Progesterone Replacement Therapy
      - HGH replacement therapy
      - Thyroid hormone replacement therapy
      - Testosterone Replacement Therapy
      - Parathyroid Hormone replacement
    - Kuwait Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
      - Oral
      - Parenteral
      - Transdermal
      - Others
    - Kuwait Hormone Replacement Therapy Market, by Disease type 2018 - 2030 (USD Billion)
      - Menopause
      - Hypothyroidism
      - Male hypogonadism
      - Growth Hormone deficiency
      - Hypoparathyroidism

Hormone Replacement Therapy Market Dynamics

Driver: Increasing cases of hormonal disorders and the growing number of patients undergoing HRT

An increase in the number of women reaching menopause and a widening of the menopausal window from 40 to 60 years of age are among the factors expected to drive market growth. Similarly, the number of patients undergoing testosterone treatment is also anticipated to increase in the next 7 years. Various studies indicate that the risk of hypogonadism grows with increasing age, and hence men above the age of 60 are more susceptible to this disease. According to the University of Wisconsin Hospitals and Clinics Authority, the prevalence of hypogonadism increases with age, and around 12% of men in their 50s and 19% of men in their 60s suffer from hypogonadism in the U.S. It also reported that in most cases, hypogonadism remains underdiagnosed and undertreated. However, increasing awareness about such diseases is anticipated to boost market growth. Cases of growth hormone deficiencies such as Turner syndrome, Cushing's syndrome, and short stature are also rising. According to statistics provided by the CDC, preterm birth affects one in every 10 infants born in the U.S. Hence, with rising awareness and increasing screening in newborns, hormonal replacement therapy is expected to be increasingly used to treat such deficiencies. The rising incidence of growth hormone-related disorders such as Prader–Willi Syndrome (PWS) is also expected to support market growth. According to a 2021 published report, its prevalence is estimated to be one in 8,000 in rural Sweden. In Western Japan, it is approximately one per 16,000 people, and in the UK, it is about one per 45,000 people.

Driver: Technological developments in drug delivery systems

The introduction of new drug delivery systems for hormone replacement such as pen-based technology and nanoparticle-based transdermal patches that facilitate ease of administration, improve efficacy, and enable optimum therapeutic profiling is expected to drive the market. The increasing focus of players on developing alternative routes and drug delivery systems is leading to higher patient compliance, thereby propelling market growth. Moreover, key players are engaged in the development of products with different formulations to increase patient acceptability and compliance, which may further boost the market growth. Additionally, the increasing involvement of key players such as Ascendis Pharma A/S and Pfizer, Inc. in the development of novel therapies is resulting in the introduction of new products in the market.

Restraint: High treatment costs

The duration of hormone replacement therapies differs from patient to patient. This treatment is generally expensive, which is a key factor limiting market growth. For instance, hormone replacement therapy by injectable costs around USD 288 to USD 1,440 for insured patients and USD 480 to USD 4,800 for uninsured patients, with the administration of the drug needed around 52 to 156 times on an annual basis. Furthermore, the average annual cost of pellets for men and women was found to be USD 1,400 to USD 2,100 and USD 1,050 to USD 1,400 respectively, covering two to four procedures per year. In addition, the average annual cost for creams, gels, and patches was found to be USD 60 to USD 360 and USD 120 to USD 1,020 for insured and uninsured patients respectively. Hence, these treatments are costly and inaccessible for lower & middle-class patients, thereby limiting market growth, especially in developing countries. Moreover, prices of hormone replacement therapies, such as hGH injection, vary based on brand and source; in the U.S., it may cost from USD 1,000 to USD 5,000 per month from a legitimate company. Moreover, the high cost of growth hormone therapy may limit the choice of brands available in the region, especially in low- and middle-income countries.

What Does This Report Include?

This section will provide insights into the contents included in this hormone replacement therapy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Hormone replacement therapy market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Hormone replacement therapy market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.